Search

Your search keyword '"Choi, Murim"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Choi, Murim" Remove constraint Author: "Choi, Murim" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
118 results on '"Choi, Murim"'

Search Results

1. Single-cell RNA sequencing of peripheral blood links cell-type-specific regulation of splicing to autoimmune and inflammatory diseases

6. Variants in the WDR44 WD40-repeat domain cause a spectrum of ciliopathy by impairing ciliogenesis initiation

7. Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues

8. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

11. A database of 5305 healthy Korean individuals reveals genetic and clinical implications for an East Asian population

12. The Korean undiagnosed diseases program phase I: expansion of the nationwide network and the development of long-term infrastructure

14. Polygenic Landscape of Cryptogenic New‐Onset Refractory Status Epilepticus: A Comprehensive Whole‐Genome Sequencing Study.

17. Melatonin alleviates myocardial dysfunction through inhibition of endothelial‐to‐mesenchymal transition via the NF‐κB pathway

21. Microglia Gravitate toward Amyloid Plaques Surrounded by Externalized Phosphatidylserine via TREM2.

22. Moderation of thyroid hormones for the relationship between amyloid and tau pathology.

27. Data from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

28. Supplementary Figures S1 - S11 from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

29. Supplementary Table S1 from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

30. Supplementary Methods, Table S2 from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

31. Supplementary Figure S1 Details from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

35. Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia

36. Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia

40. Systematic analysis of inheritance pattern determination in genes that cause rare neurodevelopmental diseases

44. A database of 5,305 healthy Korean individuals reveals genetic and clinical implications for an East Asian population

45. Multi‐Omics‐Based Autophagy‐Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology

46. The Korean Undiagnosed Diseases Program Phase I: Expansion of the Nationwide Network and the Development of Long-term Infrastructures

48. RNA‐seq profiling of tubulointerstitial tissue reveals a potential therapeutic role of dual anti‐phosphatase 1 in glomerulonephritis

49. Transcriptome-based variant calling and aberrant mRNA discovery enhance diagnostic efficiency for neuromuscular diseases

Catalog

Books, media, physical & digital resources